These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 16951204

  • 1. Mitogen-activated protein kinase phosphatase-1 is required for cisplatin resistance.
    Wang Z, Xu J, Zhou JY, Liu Y, Wu GS.
    Cancer Res; 2006 Sep 01; 66(17):8870-7. PubMed ID: 16951204
    [Abstract] [Full Text] [Related]

  • 2. ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cells.
    Wang J, Zhou JY, Wu GS.
    Cancer Res; 2007 Dec 15; 67(24):11933-41. PubMed ID: 18089824
    [Abstract] [Full Text] [Related]

  • 3. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death.
    Zhou JY, Liu Y, Wu GS.
    Cancer Res; 2006 May 01; 66(9):4888-94. PubMed ID: 16651445
    [Abstract] [Full Text] [Related]

  • 4. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
    Vicent S, Garayoa M, López-Picazo JM, Lozano MD, Toledo G, Thunnissen FB, Manzano RG, Montuenga LM.
    Clin Cancer Res; 2004 Jun 01; 10(11):3639-49. PubMed ID: 15173070
    [Abstract] [Full Text] [Related]

  • 5. Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression.
    Serini S, Trombino S, Oliva F, Piccioni E, Monego G, Resci F, Boninsegna A, Picci N, Ranelletti FO, Calviello G.
    Apoptosis; 2008 Sep 01; 13(9):1172-83. PubMed ID: 18679798
    [Abstract] [Full Text] [Related]

  • 6. Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin.
    Rojo F, González-Navarrete I, Bragado R, Dalmases A, Menéndez S, Cortes-Sempere M, Suárez C, Oliva C, Servitja S, Rodriguez-Fanjul V, Sánchez-Pérez I, Campas C, Corominas JM, Tusquets I, Bellosillo B, Serrano S, Perona R, Rovira A, Albanell J.
    Clin Cancer Res; 2009 May 15; 15(10):3530-9. PubMed ID: 19417026
    [Abstract] [Full Text] [Related]

  • 7. Evidence that mitogen-activated protein kinase phosphatase-1 induction by proteasome inhibitors plays an antiapoptotic role.
    Small GW, Shi YY, Edmund NA, Somasundaram S, Moore DT, Orlowski RZ.
    Mol Pharmacol; 2004 Dec 15; 66(6):1478-90. PubMed ID: 15448190
    [Abstract] [Full Text] [Related]

  • 8. Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance.
    Small GW, Shi YY, Higgins LS, Orlowski RZ.
    Cancer Res; 2007 May 01; 67(9):4459-66. PubMed ID: 17483361
    [Abstract] [Full Text] [Related]

  • 9. Insulin resistance affects the cytoprotective effect of insulin in cardiomyocytes through an impairment of MAPK phosphatase-1 expression.
    Morisco C, Marrone C, Trimarco V, Crispo S, Monti MG, Sadoshima J, Trimarco B.
    Cardiovasc Res; 2007 Dec 01; 76(3):453-64. PubMed ID: 17698050
    [Abstract] [Full Text] [Related]

  • 10. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase.
    Takeuchi K, Shin-ya T, Nishio K, Ito F.
    FEBS J; 2009 Mar 01; 276(5):1255-65. PubMed ID: 19175673
    [Abstract] [Full Text] [Related]

  • 11. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
    Chattopadhyay S, Machado-Pinilla R, Manguan-García C, Belda-Iniesta C, Moratilla C, Cejas P, Fresno-Vara JA, de Castro-Carpeño J, Casado E, Nistal M, Gonzalez-Barón M, Perona R.
    Oncogene; 2006 Jun 01; 25(23):3335-45. PubMed ID: 16462770
    [Abstract] [Full Text] [Related]

  • 12. Glutamine protects mice from lethal endotoxic shock via a rapid induction of MAPK phosphatase-1.
    Ko HM, Oh SH, Bang HS, Kang NI, Cho BH, Im SY, Lee HK.
    J Immunol; 2009 Jun 15; 182(12):7957-62. PubMed ID: 19494320
    [Abstract] [Full Text] [Related]

  • 13. Expression of kinase suppressor of Ras1 enhances cisplatin-induced extracellular signal-regulated kinase activation and cisplatin sensitivity.
    Kim M, Yan Y, Kortum RL, Stoeger SM, Sgagias MK, Lee K, Lewis RE, Cowan KH.
    Cancer Res; 2005 May 15; 65(10):3986-92. PubMed ID: 15899786
    [Abstract] [Full Text] [Related]

  • 14. Possible involvement of mitogen-activated protein kinase phosphatase-1 (MKP-1) in thyrotropin-releasing hormone (TRH)-induced prolactin gene expression.
    Oride A, Kanasaki H, Purwana IN, Miyazaki K.
    Biochem Biophys Res Commun; 2009 May 15; 382(4):663-7. PubMed ID: 19289102
    [Abstract] [Full Text] [Related]

  • 15. Curcumin attenuates ethanol-induced toxicity in HT22 hippocampal cells by activating mitogen-activated protein kinase phosphatase-1.
    Pae HO, Jeong SO, Zheng M, Ha HY, Lee KM, Kim EC, Kim DH, Hwang SY, Chung HT.
    Neurosci Lett; 2009 Apr 10; 453(3):186-9. PubMed ID: 19429032
    [Abstract] [Full Text] [Related]

  • 16. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC, Yang CR, Cheng CL, Raung SL, Hung YY, Chen CJ.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):49-60. PubMed ID: 17341418
    [Abstract] [Full Text] [Related]

  • 17. Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance.
    Brozovic A, Osmak M.
    Cancer Lett; 2007 Jun 18; 251(1):1-16. PubMed ID: 17125914
    [Abstract] [Full Text] [Related]

  • 18. c-Jun NH2 terminal kinase activation and decreased expression of mitogen-activated protein kinase phosphatase-1 play important roles in invasion and angiogenesis of urothelial carcinomas.
    Shimada K, Nakamura M, Ishida E, Higuchi T, Tanaka M, Ota I, Konishi N.
    Am J Pathol; 2007 Sep 18; 171(3):1003-12. PubMed ID: 17690186
    [Abstract] [Full Text] [Related]

  • 19. Sanguinarine induces apoptosis in A549 human lung cancer cells primarily via cellular glutathione depletion.
    Jang BC, Park JG, Song DK, Baek WK, Yoo SK, Jung KH, Park GY, Lee TY, Suh SI.
    Toxicol In Vitro; 2009 Mar 18; 23(2):281-7. PubMed ID: 19135517
    [Abstract] [Full Text] [Related]

  • 20. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2.
    Chang HL, Wu YC, Su JH, Yeh YT, Yuan SS.
    J Pharmacol Exp Ther; 2008 Jun 18; 325(3):841-9. PubMed ID: 18337475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.